EDGAR Filing Documents for 0001213900-23-058862

Form F-1 - Registration statement for certain foreign private issuers:

SEC Accession No. 0001213900-23-058862

Filing Date

2023-07-21

Accepted

2023-07-21 16:27:15

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	REGISTRATION STATEMENT	ff12023_neurosensetherap.htm	F-1	753554
2	OPINION OF GOLDFARB GROSS SELIGMAN & CO., ISRAELI COUNSEL TO THE REGISTRANT	ff12023ex5-1_neurosense.htm	EX-5.1	11600
3	OPINION OF COVINGTON & BURLING LLP, U.S. COUNSEL TO THE REGISTRANT	ff12023ex5-2_neurosense.htm	EX-5.2	11167
4	SUBSIDIARIES OF THE REGISTRANT	ff12023ex21-1_neurosense.htm	EX-21.1	1916
5	CONSENT OF SOMEKH CHAIKIN (MEMBER FIRM OF KPMG INTERNATIONAL), INDEPENDENT REGIS	ff12023ex23-1_neurosense.htm	EX-23.1	1590
6	FILING FEE TABLE	ff12023ex-fee_neurosense.htm	EX-FILING FEES	15404
7	GRAPHIC	tneuro_logo.jpg	GRAPHIC	130396
8	GRAPHIC	timage_001.jpg	GRAPHIC	265787
9	GRAPHIC	ex5-1_001.jpg	GRAPHIC	14080
10	GRAPHIC	ex5-1_002.jpg	GRAPHIC	11803
11	GRAPHIC	ex5-1_003.jpg	GRAPHIC	13523
12	GRAPHIC	ex5-2_001.jpg	GRAPHIC	8621
13	GRAPHIC	ex5-2_002.jpg	GRAPHIC	6380
	Complete submission text file	0001213900-23-058862.txt		1417807

Mailing Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562

Business Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562 972-9-9531142

NeuroSense Therapeutics Ltd. (Filer) CIK: 0001875091 (see all company filings)